Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001586735 | SCV001820583 | uncertain significance | not provided | 2023-04-26 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Ambry Genetics | RCV002440825 | SCV002747900 | uncertain significance | Cardiovascular phenotype | 2023-04-26 | criteria provided, single submitter | clinical testing | The p.T982I variant (also known as c.2945C>T), located in coding exon 6 of the TNXB gene, results from a C to T substitution at nucleotide position 2945. The threonine at codon 982 is replaced by isoleucine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003941034 | SCV004762792 | likely benign | TNXB-related disorder | 2019-10-04 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |